Anavex Life Sciences Corp (AVXL)

[end2war]

The intraday low today of $14.75, was brief creating a reversal back up to the close of $15.67, forming what is known in technical analysis as a doji candlestick. This type of reversal formation is often found to mark the low of a downward price move, and frequently marks a multiday bottom.

A complimentary technical formation resulting from the recent PPS dip, that also often tends to provide upward pressure on PPS, and confirms the potential strenght of the doji, was the filling of a latent gap at $15.70 yesterday.

Coupling with the upward pressure of this technical formation of the gap close and doji, we have the upcoming two conferences, that will bring fresh attention on AVXL next week.

This is an especially important opportunity for DR. Missling potentially to discuss the expected readout from the AVATAR study which is expected any time now "around the YE2021." If AVXL is able to release its expected PR on the topline results of the PH2 trial called AVATAR in retts S. and/or the PH1 trial testing the safety of AVXLs new S1R agonist A3-71, then this new data can be featured and explained to a wide audience during the conferences.

Even if not released in time for the Conferences, it is expected soon, so this data can become fundamental data (if positive as expected) to provide aditional upward vector forces on the PPS, and can eventually lead to a new high in AVXL's PPS if the data merits that.